Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Erlangen-Nürnberg Medical School
University of Chicago
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Wake Forest University Health Sciences
Jazz Pharmaceuticals
Dana-Farber Cancer Institute
AstraZeneca
Janssen Pharmaceutical K.K.
Mayo Clinic
Baylor College of Medicine
Avacta Life Sciences Ltd
Mayo Clinic
Brigham and Women's Hospital
University of Nebraska
NRG Oncology
University Health Network, Toronto
Big Ten Cancer Research Consortium
Hoffmann-La Roche